Kari Grønås
Director/Board Member at SPAGO NANOMEDICAL AB
Net worth: 4 185 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Audun Tornes | M | - | - | |
| Mats Hansen | M | 53 | 9 years | |
| Anne Hovi Worsøe | F | 60 | 3 years | |
| Oskar Axelsson | M | 62 | 17 years | |
| Carlos de Sousa | M | 66 | 4 years | |
| Jonas Hallén | M | - |
Arxx Therapeutics AS
 Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | 5 years |
| Jörg Klingelhöfer | M | - |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | 6 years |
| Hans Vassgård Eid | M | 57 | - | |
| Rune Skeie | M | 51 | 6 years | |
| Gudrun Trøite | M | - | - | |
| Nicklas Westerholm | M | 48 | 5 years | |
| Hanna Olsson | F | 44 | 5 years | |
| Jens Bjørheim | M | - | - | |
| Kjetil Hestdal | M | 64 |
K & K AS
 K & K AS Miscellaneous Commercial ServicesCommercial Services K & K AS manages securities. The company was founded on June 26, 2002 and is headquartered in Oslo, Norway. | 22 years |
| Birgitte Gangmark Villmo | F | - |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | - |
| Haakon Stenrod | M | 44 | 4 years | |
| Ingunn Hagen Westgaard | F | - | - | |
| Paul Hargreaves | M | 55 | 3 years | |
| Mc Callion Orla | M | - | 3 years | |
| Debra Stephanie Barker | M | 61 | 5 years | |
| Gustav Gaudernack | M | - | - | |
| Susanne Stuffers | M | 43 |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | - |
| Antonius Berkien | M | 56 | 4 years | |
| Øyvind Eriksen | M | 60 |
Norwegian Cancer Society
| - |
| Øivind Foss | M | - | - | |
| Christian Schweiger | M | 57 |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | 4 years |
| Henrik Schüssler | M | 61 | 9 years | |
| Alan Henry Raffensperger | M | 64 | 1 years | |
| Yuri Khodjamirian | M | - |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | - |
| Jónas Einarsson | M | 67 | 13 years | |
| Hans Arwidsson | M | 66 | 1 years | |
| Øystein Soug | M | 55 |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | 2 years |
| Farzad Abdi-Dezfuli | M | - |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hilde Furberg | F | 65 | 4 years | |
| Susan Foden | M | 71 | 8 years | |
| Stein Holst Annexstad | M | 80 | 3 years | |
| Øyvind Kongstun Arnesen | M | 67 | - | |
| Petter Nielsen | M | - | 3 years | |
| James Barnes | M | - | 4 years | |
| Sten Nilsson | M | 76 | 10 years | |
| Murray Yule | M | - | 7 years | |
| Peter Leander | M | 67 | 11 years | |
| Debbie Molyneux | F | - | 4 years | |
| Eva Dugstad | F | - | - | |
| Dominic Smethurst | M | 50 | - | |
| Tone Bjaaland | M | - | - | |
| Grunde Eriksen | M | - | - | |
| Kristin Louise A. Wilhelmsen | F | 62 | 4 years | |
| Eugen Steiner | M | 70 | 4 years | |
| Mikael Lönn | M | 75 | - | |
| Bengt Håkan Englund | M | 72 | 3 years | |
| Jon-Øyvind Eriksen | M | 60 | 7 years | |
| Aitana Peire | M | - | 3 years | |
| Anthony Brown | M | - | 4 years | |
| Alan Barge | M | - | 1 years | |
| Pamela A. Trail | M | 68 | - | |
| Tove Sivik Sonne | F | 44 | 8 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Norway | 45 | 78.95% |
| Sweden | 12 | 21.05% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kari Grønås
- Personal Network
